ADVIA CENTAUR XPT AFP ASSAY N/A 03974780

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-01-10 for ADVIA CENTAUR XPT AFP ASSAY N/A 03974780 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[64343789] No issues were identified for the advia centaur xpt unit 1 by the siemens field service engineer (fse). No problems were found in the event log at the time of the event. A secondary tube was used for the run on the advia centaur xpt unit 1. The sample was centrifuged at 3000 rpm for 5 minutes. The same secondary tube was used for the run on unit 3. The sample was not centrifuged prior to running on unit 3. A new secondary tube was used for the run on unit 12. The sample was not centrifuged prior to running on unit 12. The instructions for use (ifu) recommends centrifuging samples at 1000 x gravitational force (g) for 15-20 minutes to remove particulates. It is possible that some sort of particulate matter in the sample caused the initial elevated result. The cause for the discordant afp results is unknown. It is possible that insufficient centrifugation may have caused the initial elevated result. The instrument is performing within specification. No further evaluation of the device is required. The ifu states in the preparing the samples section: "before placing samples on the system, ensure that samples have the following characteristics: samples are free of fibrin or other particulate matter. Remove particulates by centrifugation at 1000 x g for 15-20 minutes. Samples are free of bubbles. " the ifu states in the interpretation of results section: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings. "
Patient Sequence No: 1, Text Type: N, H10


[64343790] A falsely elevated advia centaur xpt afp result was obtained for a patient sample. The patient sample was repeated on two other advia centaur xpt instruments. Both results were lower. Patient treatment was not prescribed or altered. There was no report of adverse health consequences due to the discordant afp results.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1219913-2016-00283
MDR Report Key6237012
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-01-10
Date of Report2017-01-10
Date of Event2016-12-16
Date Mfgr Received2016-12-16
Device Manufacturer Date2016-06-28
Date Added to Maude2017-01-10
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. EIMAN SULIEMAN
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604603
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Remedial ActionIN
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XPT AFP ASSAY
Generic NameKIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS
Product CodeLOK
Date Received2017-01-10
Model NumberN/A
Catalog Number03974780
Lot Number041181
Device Expiration Date2017-09-28
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Address511 BENEDICT AVENUE TARRYTOWN NY 105915097 US 105915097


Patients

Patient NumberTreatmentOutcomeDate
10 2017-01-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.